CompletedNCT00136786
Memantine or bupropion in a laboratory model of smoking relapse
About this title
Read the official source — NCT00136786Placebo comparisonAges 21–45United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 45 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateDecember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 45 Years
- Official registry ID
- NCT00136786
- Official title
Show the full official title
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Memantine.
Who was this study for?
Listed age limits: 21 years to 45 years.
